Martin Huber
Corporate Officer/Principal at NAUTILUS BIOTECHNOLOGY, INC.
Profile
Martin Huber is the founder of Quantapore, Inc. which was founded in 2009.
He held the title of Chief Executive Officer & Director.
Currently, he is the VP-Biochemistry & Flow Cell Development at Nautilus Biotechnology, Inc. where he started in 2023.
Dr. Huber has a graduate and doctorate degree from the University of Vienna.
Martin Huber active positions
| Companies | Position | Start |
|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 2023-10-31 |
Former positions of Martin Huber
| Companies | Position | End |
|---|---|---|
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Founder | - |
Training of Martin Huber
| University of Vienna | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Martin Huber
